CTRI/2024/05/067778尚未招募3 期
A prospective, open label, single centre study for evaluation of efficacy and safety of Appelite Syrup in the management of Dyspepsia (Indigestion),Loss of Appetite And Acidity - NI
Healing Hands & Herbs Pvt. Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients aged above 18 years of age. 2.Patient with a diagnosis of Dyspepsia (indigestion) or loss of appetite or acidity. 3.Patient or Parent or legal guardian willing to give a written informed consent or parental consent or assent form. 4.Able to or Willing to strictly adhere to the investigator’s prescription.
排除标准
- •1.Individuals were excluded if they had taken any medications that might interfere with the action of the study medications prior to the start of the study or during the study.
- •2.Patients with a medical history and diagnosis of Diabetes were excluded from the study.
- •3.Female subjects who are pregnant or lactating or planning to become pregnant during the study period. Females who are not ready to use acceptable contraceptive methods during the course
研究者
相似试验
进行中（未招募）
1 期
Study to investigate the effect of riociguat on right heart size and function in pulmonary hypertensioSymptomatic pulmonary arterial hypertension with a mean pulmonary artery pressure >20 mmHg and pulmonary vascular resistance =2 Wood Units, pulmonary arterial wedge pressure =15 mmHg (Group I / Nice Clinical Classification of Pulmonary Hypertension (PH)) or CTEPH (Group IV) with hemodynamics as stated above defined as inoperable measured at least 3 months after start of full anticoagulation or with persisting or recurrent PH after pulmonary endarterectomy at least 6 months after surgeryMedDRA version: 20.0Level: HLTClassification code 10037401Term: Pulmonary hypertensionsSystem Organ Class: 100000004855EUCTR2020-005462-34-DEThoraxklinik Heidelberg gGmbH30
进行中（未招募）
1 期
An open-label, prospective, single centre study of the effects of Riociguat on RIght VEntricular size and function in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary HypertensioPulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary HypertensionMedDRA version: 20.0Level: HLTClassification code: 10037401Term: Pulmonary hypertensions Class: 10047065CTIS2023-509696-17-00Thoraxklinik Heidelberg gGmbH30
尚未招募
Unknown
Open label study for Evaluation of glycemic index (GI) of Diabliss Herbal Sugar for food classification per ISO 26642 test procedure among healthy subjectsCTRI/2024/07/070733Diabliss Consumer Products Pvt Limited
已完成
不适用
Single center, open-label study investigating the excretion balance, pharmacokinetics and metabolism of a single oral dose of [14C]-labeled RO6889450 in healthy male volunteers10039628SchizophreniaNL-OMON51079F. Hoffman-La Roche Ltd6
尚未招募
不适用
A single-center, prospective, open-label study investigating the effect of Ninjin'yoeito on frailty in hemodialysis patients.frailty in hemodialysis patientsJPRN-UMIN000052058Japanese Red Cross Kumamoto Hospital40